Innovative Medicines Initiative 8th Call


The aim of IMI is to support pre-competitive pharmaceutical research and development to foster the development of safe and more effective medicines for patients throughremoving identified bottlenecks in the drug development process and enhance Europe’s competitiveness by ensuring that its biopharmaceutical sector remains a dynamic hightechnology sector.

The IMI 8th Call 2012 for proposals will have 2 topics covering the following key research priorities:

  • Antimicrobial resistance (two topics)
  • European induced pluripotent stem cell bank
  • Developing an aetiology-based taxonomy of human disease
Termini Oficial

The Innovative Medicine Initiative Joint Undertaking (IMI JU) has published on its web the information necessary to submit an Expression of Interest in response to IMI 8th Call 2012

Estàs interessat?

Omple el següent formulari per rebre més informació: